Finland, Feb. 9 -- Finland based Recordati AB has secured contract from HUS Group, the joint authority for Helsinki and Uusimaa for Pharmaceutical products - Purchase of osilodrostat (Isturisa 1 mg, 5 mg and 10 mg).. The value of the contract is worth 60000000 EUR.

Published by HT Digital Content Services with permission from Pivotal Sources....